Drug Discovery Opinion

The identification of host genes that are exploited by bacteria and viruses could lead to new therapeutic targets but gene inactivation by mutation is inefficient in (diploid) mammalian somatic cells because when one copy is inactivated, the second copy usually remains active and continues to provide protein. Genetic experiments are typically carried out in model systems such as yeast cells which can exist in a haploid state with only one copy of each gene, but researchers at the Whitehead Institute for Biomedical Research have now developed an assay system based on a human cell line, KBM7, that exists in a haploid state except for chromosome 8, which is present in two copies. The team inactivated individual genes by insertional mutagenesis and then assessed the ability of bacterial toxins or viruses to kill the cells. A variety of pathogenic bacteria secrete potent toxins known as cytolethal distending toxins (CDTs) which cause cytotoxicity by inducing breaks in cellular DNA, resulting in arrest of the cell cycle. By identifying mutagenized KBM7 cells that were resistant to CDT from E. Coli, the gene encoding sphingomyelin synthase I and a gene encoding a putative G protein-coupled receptor were shown to cause susceptibility to CDTs. Examination of mutant cells resistant to influenza virus A infection revealed an enzyme and a transporter protein involved in sialic acid biochemistry as key to susceptibility. Because native anthrax toxin is not cytotoxic for KBM7 cells, the researchers used a modified toxin to probe mutagenized cells and found that a previously uncharacterised component of the dipthamide biosynthetic pathway confers sensitivity to toxin-mediated cell death.

As well as allowing the identification of genes involved in susceptibility to infection by bacteria and viruses, the mutagenized KBM7 cells could be used to study other disease-associated molecular networks where a distinct phenotype exists.

The study is published in Science.

Related posts:

1. siRNA Experiments Identify Ebola Virus Drug Targets Antiviral drugs that exclusively target viral factors rather than host cell processes offer the possibility of fewer side effects but...
2. Three New Kinase Targets for Alzheimer’s Disease Neurofibrillary tangles (NFT) are a hallmark of Alzheimer’s disease (AD) and correlate strongly with synaptic loss and severity of...
3. Discovery Could Lead to Better Treatment for Bacterial Meningitis Meningitis – infection of the cerebrospinal fluid and protective membranes surrounding the brain and spinal cord – can be caused...
4. Rhes Protein Linked to Cell Death in Huntington’s Disease Huntington’s disease (HD) is an inherited neurological disorder that causes a wide range of symptoms including involuntary movements, clumsiness, lack...
5. New Drug Target for Pulmonary Arterial Hypertension Pulmonary arterial hypertension (PAH) is a progressive, debilitating disease characterised by increased resistance in pulmonary arteries, placing additional workload...

Related posts brought to you by Yet Another Related Posts Plugin.

 Email This Post

This entry was posted on Thursday, December 3rd, 2009 at 8:49 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.